As fossil fuel markets remain volatile, Epoch Biodesign is constructing a supply chain anchored in waste rather than extraction. Founder Jacob Nathan views bales of discarded textiles as equivalent to barrels of oil, minus the geopolitical price swings. The company employs a cascade of isolated enzymes to depolymerize nylon 6,6 into reusable monomers, recovering over 90% of the input material.

Unlike traditional biological recycling, Epoch bypasses live microbes, sourcing enzymes directly from industrial suppliers to maintain strict process control. This approach mirrors robust data pipelines where input consistency ensures output reliability. The only byproducts are dyes, which are captured separately. This precision allows the firm to sidestep recent market shocks, where nylon precursors spiked 150% on spot prices due to global instability.

Investors see the stability. Apparel giant Lululemon joined a $12 million funding round alongside Exantia and Kompas VC. The capital supports a demonstration facility near Imperial College London. Nathan plans to launch a commercial plant by 2028, targeting 20,000 metric tons of monomer annually. Once the nylon pipeline matures, the architecture allows for repurposing toward other plastic types. For industries reliant on consistent raw materials, Epoch offers a way to decouple production from fossil carbon volatility. The move signals a shift where waste streams become predictable feedstocks, reducing dependency on external market forces that often disrupt supply chains.

Source: TechCrunch